Facial Papulopustular Eruption during the COVID-19 Pandemic in Patients Treated with EGFR Inhibitors

• Main Authors: Eleonora De Luca (Author), Pietro Sollena (Author), Lucia Di Nardo (Author), Ettore D'Argento (Author), Emanuele Vita (Author), Giampaolo Tortora (Author), Ketty Peris (Author)
• Format: Book
• Published: Hindawi Limited, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Papulopustular rash (PPR) is the most frequent cutaneous adverse event during treatment with epidermal growth factor receptor inhibitors (EGFRis). Although often mild in severity, it can impair patients' quality of life and may also be a reason for discontinuing or changing the dose of the anti...